 Zidovudine use AIDS-free homosexual men Multicenter AIDS Cohort Study MACS Zidovudine use data Multicenter AIDS Cohort Study proportion pre-AIDS participants cells AIDS-related complex zidovudine high rise AIDS incidence homosexual men ii factors zidovudine clinical trials zidovudine iii pre-AIDS patients group Data zidovudine use clinical trial participation sociodemographic clinical hematologic variables months AIDS-free homosexual men April September Overall prevalence zidovudine use prevalence zidovudine use zidovudine placebo part clinical trial visit ARC zidovudine visit visit numbers small advanced ARC participants cells symptoms treatment rates visits September lymphocyte levels zidovudine many high-risk pre-AIDS individuals finding range sociodemographic hematologic clinical variables factors initiation zidovudine therapy clinical trials multivariate analyses number consistent predictor initiation therapy study visits deficit odds ratios C.I visit C.I visit Symptom status education level zidovudine visits low predictive power clinical variables raises possibility nonclinical factors MACS drug cost third-party insurance restrictions individual preferences important role zidovudine use comparisons seropositive participants clinical trials zidovudine rest study population important differences demographic major clinical variables clinical trial participants zidovudine nonusers study